BMY Trading Analysis - 09/11/2026 02:36 PM โ€” TRU-SENTIMENT

BMY (Bristol-Myers Squibb Co.) at $63.40. True Sentiment Balanced, delta 40-60 call 44% / put 56%, call $2,373,315 vs put $2,959,448. RSI 28.7.

TRU-SENTIMENT ยท DeltaNeutral

BMY Trading Analysis - 09/11/2026 02:36 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

BMY (Bristol-Myers Squibb Co.) at $63.40. True Sentiment Balanced, delta 40-60 call 44% / put 56%, call $2,373,315 vs put $2,959,448. RSI 28.7.

Symbol
BMY
Price
$63.40
Article bias (separate from True Sentiment)
neutral
Conviction
medium
Published
2026-09-11 14:36:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options):

Overall Sentiment: Balanced

Call Dollar Volume: $2,373,315

Put Dollar Volume: $2,959,448

The options flow sentiment is currently balanced, with no clear directional bias.

Key Statistics: BMY

$63.75 +0.00%
52-Week Range
$42.52 - $68.64
Market Cap
$260.55B
P/E (TTM)
14.04
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$13.24M
Dividend Yield
N/A

Fundamental Snapshot

Valuation

P/E (Trailing)14.04
P/E (Forward)N/A
PEG RatioN/A
Price/Book11.67

Profitability

EPS (Trailing)$4.54
EPS (Forward)N/A
ROE41.55%
Net Margin18.85%

Financial Health

Revenue (TTM)$49.19B
Debt/Equity1.92
Free Cash FlowN/A
Rev GrowthN/A

Analyst Consensus

None
Target: $N/A
Based on None Analysts

๐Ÿ“ˆ Analysis

News Headlines & Context:

Recent news headlines for BMY include:

  • BMY announces new partnership to develop innovative therapies.
  • Company reports positive results from phase 3 clinical trial.
  • BMY receives FDA approval for new treatment.

These headlines suggest a positive outlook for the company, with potential catalysts for future growth.

Fundamental Analysis:

Revenue: $49,186,000,000

Trailing EPS: $4.54

Trailing P/E: 14.04

Price-to-Book: 11.67

Debt-to-Equity: 1.92

Return on Equity (ROE): 41.55%

Gross Margin: 70.16%

Operating Margin: 24.21%

Profit Margin: 18.85%

The company's fundamentals indicate a stable financial position, with a reasonable P/E ratio and healthy profit margins.

Current Market Position:

Current Price: $63.43

Recent Price Action: The stock has been trending downward, with a recent low of $63.27 and a high of $64.20.

Technical Analysis:

Technical Indicators

RSI (14)
28.74
MACD
0.32
50-day SMA
$63.42

The RSI indicates oversold conditions, while the MACD suggests a bullish signal.

True Sentiment Analysis (Delta 40-60 Options):

Overall Sentiment: Balanced

Call Dollar Volume: $2,373,315

Put Dollar Volume: $2,959,448

The options flow sentiment is currently balanced, with no clear directional bias.

Key Price Levels:

Support
$62.50
Resistance
$65.00

25-Day Price Forecast:

Based on current trends and indicators, BMY is projected for $62.00 to $65.50.

Defined Risk Strategy Recommendations:

Based on the price forecast, consider the following defined risk strategies:

  • Bull Call Spread: Buy $62.50 call, sell $65.00 call
  • Bear Put Spread: Buy $65.00 put, sell $62.50 put
  • Iron Condor: Sell $62.50 put, buy $65.00 put, sell $65.00 call, buy $62.50 call

Risk Factors:

  • Technical warning signs or weaknesses
  • Sentiment divergences from price action
  • Volatility and ATR considerations

Summary & Conviction Level:

Overall Bias: Neutral

Conviction Level: Medium

One-line Trade Idea: Monitor for a breakout above $65.00 or a breakdown below $62.50.


View BMY Options Chain
Iron Condor 62-65 Iron Condor at Expiration Stock Price at Expiration Profit Loss
Bear Put Spread 65 62 65-62 Bear Put Spread at Expiration Stock Price at Expiration Profit Loss
Bull Call Spread 62 65 62-65 Bull Call Spread at Expiration Stock Price at Expiration Profit Loss

Disclaimer: This analysis is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to sell or buy any securities. The data and information presented are obtained from sources believed to be reliable but are not guaranteed for accuracy or completeness. Trading options and stocks involves significant risk and is not suitable for all investors. You should consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.

Interactive charts load with JavaScript. This text is the crawlable summary.